More than 15 years of experience with design, synthesis and structure-activity relationships of quinoline-, hydroxynaphthalene-based compounds, pyrazine and salicylanilide analogues as potential antimicrobial drugs. Leader of a scientific team that deals with design, synthesis and biological testing of new antimicrobial active agents. Cooperation with other members aimed at deeper investigation of new antimycobacterial agents and understanding of their mode of action.